Serum Institute seeks emergency use authorisation for Oxford COVID-19 vaccine Covishield in India

A day earlier, the Indian arm of US pharmaceutical giant Pfizer became the first to seek a similar approval from India's drug regulator for its own COVID-19 vaccine in the country, after securing such clearance in the UK and Bahrain.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3qxJfxw
via IFTTT